Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
, (), , , ,
Keep away from direct light
This makes retatrutide a GLP-1/GIP/glucagon triple agonist, and the first molecule of its kind to reach advanced clinical trials
Research is ongoing, and there are signals from observational studies and reviews that GLP-1 therapies could influence neuroinflammation and neurodegenerative riskbut they are not currently indicated to treat Alzheimers or Parkinsons outside clinical trials, and some trials have not met primary endpoints
US$ 20.84
US$ 29.15
US$ 26.29
US$ 24.49
US$ 24.67
US$ 29.13
US$ 28.14
US$ 21.94
US$ 24.83
US$ 24.51
US$ 26.33
